Mario Gabelli's NEO Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 100,000 shares of NeoGenomics, Inc. (NEO) worth $742,000, representing 0.01% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 38 quarters.
Based on 13F filings, Mario Gabelli has maintained a strategic position in NEO, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2018, adding 233,479 shares. Largest reduction occurred in Q3 2014, reducing 200,000 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's NeoGenomics (NEO) Holding Value Over Time
Track share changes against reported price movement
Quarterly NeoGenomics (NEO) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +84,000 | Add 525.00% | 100,000 | $7.42 |
| Q3 2025 | +5,000 | Add 45.45% | 16,000 | $7.72 |
| Q2 2025 | +11,000 | New Buy | 11,000 | $7.31 |
| Q3 2022 | -30,510 | Sold Out | 0 | $0.00 |
| Q2 2022 | -700 | Reduce 2.24% | 30,510 | $8.16 |
| Q1 2022 | +1,700 | Add 5.76% | 31,210 | $12.14 |
| Q4 2021 | -800 | Reduce 2.64% | 29,510 | $34.12 |
| Q3 2021 | -100 | Reduce 0.33% | 30,310 | $48.23 |
| Q2 2021 | +2,200 | Add 7.80% | 30,410 | $45.18 |
| Q1 2021 | -13,040 | Reduce 31.61% | 28,210 | $48.25 |
| Q4 2020 | -6,100 | Reduce 12.88% | 41,250 | $53.84 |
| Q3 2020 | -11,000 | Reduce 18.85% | 47,350 | $36.90 |
| Q2 2020 | -15,840 | Reduce 21.35% | 58,350 | $30.99 |
| Q1 2020 | -24,546 | Reduce 24.86% | 74,190 | $27.60 |
| Q4 2019 | -7,700 | Reduce 7.23% | 98,736 | $29.25 |
| Q3 2019 | -25,299 | Reduce 19.20% | 106,436 | $19.12 |
| Q2 2019 | -11,700 | Reduce 8.16% | 131,735 | $21.94 |
| Q1 2019 | -7,800 | Reduce 5.16% | 143,435 | $20.46 |
| Q4 2018 | -39,284 | Reduce 20.62% | 151,235 | $12.61 |
| Q3 2018 | -5,000 | Reduce 2.56% | 190,519 | $15.35 |
| Q2 2018 | -146,860 | Reduce 42.89% | 195,519 | $13.11 |
| Q1 2018 | +233,479 | Add 214.40% | 342,379 | $8.16 |
| Q4 2017 | +50,000 | Add 84.89% | 108,900 | $8.86 |
| Q3 2017 | -40,800 | Reduce 40.92% | 58,900 | $11.14 |
| Q2 2017 | +22,700 | Add 29.48% | 99,700 | $8.96 |
| Q1 2017 | +10,000 | Add 14.93% | 77,000 | $7.90 |
| Q4 2016 | +17,000 | Add 34.00% | 67,000 | $8.57 |
| Q2 2016 | -40,000 | Reduce 44.44% | 50,000 | $8.04 |
| Q1 2016 | +10,000 | Add 12.50% | 90,000 | $6.74 |
| Q4 2015 | -50,000 | Reduce 38.46% | 80,000 | $7.88 |
| Q3 2015 | -20,000 | Reduce 13.33% | 130,000 | $5.73 |
| Q1 2015 | +50,000 | Add 50.00% | 150,000 | $4.67 |
| Q4 2014 | +100,000 | New Buy | 100,000 | $4.17 |
| Q3 2014 | -200,000 | Sold Out | 0 | $0.00 |
| Q2 2014 | +200,000 | New Buy | 200,000 | $3.32 |
Mario Gabelli's NeoGenomics Investment FAQs
Mario Gabelli first purchased NeoGenomics, Inc. (NEO) in Q2 2014, acquiring 200,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held NeoGenomics, Inc. (NEO) for 38 quarters since Q2 2014.
Mario Gabelli's largest addition to NeoGenomics, Inc. (NEO) was in Q1 2018, adding 342,379 shares worth $2.79 M.
According to the latest 13F filing for Q1 2026, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 100,000 shares of NeoGenomics, Inc. (NEO), valued at approximately $742,000.
As of the Q1 2026 filing, NeoGenomics, Inc. (NEO) represents approximately 0.01% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in NeoGenomics, Inc. (NEO) was 342,379 shares, as reported at the end of Q1 2018.